213 related articles for article (PubMed ID: 9552326)
1. Interaction of recombinant human bone morphogenetic protein-2 with poly(d,l lactide-co-glycolide) microspheres.
Duggirala SS; Mehta RC; DeLuca PP
Pharm Dev Technol; 1996 Apr; 1(1):11-9. PubMed ID: 9552326
[TBL] [Abstract][Full Text] [Related]
2. Targeted delivery system for juxtacrine signaling growth factor based on rhBMP-2-mediated carrier-protein conjugation.
Liu HW; Chen CH; Tsai CL; Hsiue GH
Bone; 2006 Oct; 39(4):825-36. PubMed ID: 16782421
[TBL] [Abstract][Full Text] [Related]
3. Recombinant human bone morphogenetic protein-2 binding and incorporation in PLGA microsphere delivery systems.
Schrier JA; DeLuca PP
Pharm Dev Technol; 1999; 4(4):611-21. PubMed ID: 10578516
[TBL] [Abstract][Full Text] [Related]
4. Changing the pH of the external aqueous phase may modulate protein entrapment and delivery from poly(lactide-co-glycolide) microspheres prepared by a w/o/w solvent evaporation method.
Leo E; Pecquet S; Rojas J; Couvreur P; Fattal E
J Microencapsul; 1998; 15(4):421-30. PubMed ID: 9651864
[TBL] [Abstract][Full Text] [Related]
5. Porous bone morphogenetic protein-2 microspheres: polymer binding and in vitro release.
Schrier JA; DeLuca PP
AAPS PharmSciTech; 2001 Oct; 2(3):E17. PubMed ID: 14727876
[TBL] [Abstract][Full Text] [Related]
6. Controlled release of rhBMP-2 loaded poly(dl-lactic-co-glycolic acid)/calcium phosphate cement composites in vivo.
Ruhé PQ; Boerman OC; Russel FG; Spauwen PH; Mikos AG; Jansen JA
J Control Release; 2005 Aug; 106(1-2):162-71. PubMed ID: 15972241
[TBL] [Abstract][Full Text] [Related]
7. Healing of large segmental defects in rat femurs is aided by RhBMP-2 in PLGA matrix.
Lee SC; Shea M; Battle MA; Kozitza K; Ron E; Turek T; Schaub RG; Hayes WC
J Biomed Mater Res; 1994 Oct; 28(10):1149-56. PubMed ID: 7829545
[TBL] [Abstract][Full Text] [Related]
8. RhBMP-2 microspheres-loaded chitosan/collagen scaffold enhanced osseointegration: an experiment in dog.
Shi S; Cheng X; Wang J; Zhang W; Peng L; Zhang Y
J Biomater Appl; 2009 Jan; 23(4):331-46. PubMed ID: 18667455
[TBL] [Abstract][Full Text] [Related]
9. Slow and continuous application of human recombinant bone morphogenetic protein via biodegradable poly(lactide-co-glycolide) foamspheres.
Weber FE; Eyrich G; Grätz KW; Maly FE; Sailer HF
Int J Oral Maxillofac Surg; 2002 Feb; 31(1):60-5. PubMed ID: 11936402
[TBL] [Abstract][Full Text] [Related]
10. Bone regeneration of critical calvarial defect in goat model by PLGA/TCP/rhBMP-2 scaffolds prepared by low-temperature rapid-prototyping technology.
Yu D; Li Q; Mu X; Chang T; Xiong Z
Int J Oral Maxillofac Surg; 2008 Oct; 37(10):929-34. PubMed ID: 18768295
[TBL] [Abstract][Full Text] [Related]
11. Enhancement of ectopic bone formation by bone morphogenetic protein-2 released from a heparin-conjugated poly(L-lactic-co-glycolic acid) scaffold.
Jeon O; Song SJ; Kang SW; Putnam AJ; Kim BS
Biomaterials; 2007 Jun; 28(17):2763-71. PubMed ID: 17350678
[TBL] [Abstract][Full Text] [Related]
12. Effects of process and formulation parameters on characteristics and internal morphology of poly(d,l-lactide-co-glycolide) microspheres formed by the solvent evaporation method.
Mao S; Shi Y; Li L; Xu J; Schaper A; Kissel T
Eur J Pharm Biopharm; 2008 Feb; 68(2):214-23. PubMed ID: 17651954
[TBL] [Abstract][Full Text] [Related]
13. Effects of lung surfactants on rifampicin release rate from monodisperse rifampicin-loaded PLGA microspheres.
Tomoda K; Makino K
Colloids Surf B Biointerfaces; 2007 Mar; 55(1):115-24. PubMed ID: 17197161
[TBL] [Abstract][Full Text] [Related]
14. Potential of porous poly-D,L-lactide-co-glycolide particles as a carrier for recombinant human bone morphogenetic protein-2 during osteoinduction in vivo.
Boyan BD; Lohmann CH; Somers A; Niederauer GG; Wozney JM; Dean DD; Carnes DL; Schwartz Z
J Biomed Mater Res; 1999 Jul; 46(1):51-9. PubMed ID: 10357135
[TBL] [Abstract][Full Text] [Related]
15. The evaluation of lyophilized polymer matrices for administering recombinant human bone morphogenetic protein-2.
Duggirala SS; Rodgers JB; DeLuca PP
Pharm Dev Technol; 1996 Jul; 1(2):165-74. PubMed ID: 9552343
[TBL] [Abstract][Full Text] [Related]
16. Effect of encapsulation or grafting on release kinetics of recombinant human bone morphogenetic protein-2 from self-assembled poly(lactide-co-glycolide ethylene oxide fumarate) nanoparticles.
Mercado AE; Jabbari E
Microsc Res Tech; 2010 Sep; 73(9):824-33. PubMed ID: 20232367
[TBL] [Abstract][Full Text] [Related]
17. Apatite nano-crystalline surface modification of poly(lactide-co-glycolide) sintered microsphere scaffolds for bone tissue engineering: implications for protein adsorption.
Jabbarzadeh E; Nair LS; Khan YM; Deng M; Laurencin CT
J Biomater Sci Polym Ed; 2007; 18(9):1141-52. PubMed ID: 17931504
[TBL] [Abstract][Full Text] [Related]
18. [An experimental study on ectopic osteogenesis of autologous micromorselized bone compounded with slow-released rhBMP-2/PLGA microsphere].
Ji Y; Yan J; Xu G
Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi; 2007 Nov; 21(11):1184-90. PubMed ID: 18069471
[TBL] [Abstract][Full Text] [Related]
19. Three-dimensional fibrous PLGA/HAp composite scaffold for BMP-2 delivery.
Nie H; Soh BW; Fu YC; Wang CH
Biotechnol Bioeng; 2008 Jan; 99(1):223-34. PubMed ID: 17570710
[TBL] [Abstract][Full Text] [Related]
20. Effect of a freeze-dried CMC/PLGA microsphere matrix of rhBMP-2 on bone healing.
Schrier JA; Fink BF; Rodgers JB; Vasconez HC; DeLuca PP
AAPS PharmSciTech; 2001 Oct; 2(3):E18. PubMed ID: 14727877
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
